Dashboard
Manage Tickers

ENDPQEndo International plc

OTC endo.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 0.0006
-- x --
-- x --
-- - --
$ 0.00 - $ 0.08
9,967
na
141,131
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-06-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-06-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-26-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-04-2019 09-30-2019 10-Q
19 08-05-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 02-28-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-01-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-02-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-04-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bankrupt-generic-drugmaker-endo-secures-court-approval-for-600m-opioid-epidemic-compensation-plan
Bankrupt Generic Drugmaker Endo Secures Co...
01/11/2024 19:09:12

Endo International (OTC: ENDPQ) has gained approval from U.S. Bankruptcy Court Judge James Garrity to initiate the solicitation...

generic-drugmaker-endos-bankruptcy-lenders-suggest-465m-payment-to-settle-dispute-with-federal-entities-report
Generic Drugmaker Endo's Bankruptcy: Lende...
11/22/2023 11:56:50

Endo International's (OTC: ENDPQ) lenders have reportedly proposed a fresh deal to settle with U.S.

rite-aid-once-top-drugstore-chain-lost-over-80-of-stock-value-in-one-year-opioid-litigation-takes-toll
Rite Aid Once Top Drugstore Chain Lost Ove...
08/25/2023 17:52:05

Rite Aid Corp (NYSE: RAD) is reportedly on the brink of filing for bankruptcy amidst many lawsuits over its purported role in t...

Core News & Articles
Endo And Premier, Inc. Collaborate To Addr...
07/17/2023 20:31:59

Strategic effort aims to bring stable, quality supply to providers and enhanced pricing predictability for critical labor and d...

Core News & Articles
Florida Lawmakers Approve Six-Week Abortio...
04/13/2023 20:40:51

-Reuters

elon-musk-tells-employees-tesla-will-be-most-valuable-company-on-earth-sam-bankman-fried-set-to-enter-plea-on-fraud-case-twitter-should-feel-faster-todays-top-stories
Elon Musk Tells Employees Tesla Will Be 'M...
12/29/2022 12:59:45

Reuters

novartis-settles-antitrust-cases-related-to-generic-entry-for-hypertension-drug
Novartis Settles Antitrust Cases Related T...
12/29/2022 12:18:25

Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. la...

venus-concept-taps-endos-former-ceo-as-new-chief-executive-withdraws-fy22-guidance
Venus Concept Taps Endo's Former CEO As Ne...
10/03/2022 17:36:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION